Castle Biosciences, Inc. · NASDAQ:CSTL

Juvenal Tobin W sold 6,577 Castle Biosciences, Inc. shares (Form 4)

Traded Sep 29 to Sep 30, 2026 · Filed Oct 1, 2026

From Sep 29 to Sep 30, 2026, Juvenal Tobin W (Chief Commercial Officer) sold 6,577 Castle Biosciences, Inc. shares at an average US$35.29 for US$232K under a trading plan, leaving 52,007 shares. Filed Oct 1, 2026 (Form 4).

Sold
6,577 shares
Price
US$35.29 average (US$34.20 to US$35.50)
Value
US$232K
Holding after
52,007 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Commercial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 29, 2026Common StockSale5,543US$35.5053,041Direct
Sep 30, 2026Common StockSale1,034US$34.2052,007Direct

Source

View original at SEC

Related